From 6 to 8 December 2023, more than 1300 people from all over the world gathered in Basel, Switserland for the 34th edition of the International Symposium on ALS/MND. After three online editions, this year the MND community could come together again in person.
MND Association’s International Symposium on ALS/MND is the largest medical and scientific conference dedicated to ALS and MND research. Clinicians, researchers, health and social care professionals and even patient fellows came together to discuss the newest understanding of ALS and MND, make new connections and form new partnerships.
The three days were filled with keynote lectures, sessions on various topics from clinical trials to biomarkers and almost 400 poster presentations. One of the highlights of the Symposium was the closing session, which brought a patient with FUS-ALS trialing the drug Jacifusen onto the stage. The patient has the rare FUS mutation, which leads to an aggressive form of the disease: she wasn’t able to walk anymore and ended up in a coma. After taking the drug, she was now able to stand on the stage herself.
Read more about the Symposium here.
Relaterade nyheter
European Commission approves Tofersen as treatment for ALS-SOD1
Amylyx terminates open-label extension of the PHOENIX study
Meet the centre - Torino ALS Center (University of Torino)
